In this paper we add the evidence that not only genetic deletion of IL-33 receptor (ST2) enhance T cell mediated autoimmune inflammatory diseases but also the exogenous IL-33 has shown powerful preventive effect in a model of type 1 diabetes (Figure 1). This evidence concerns the gene IL1RL1 and type 1 diabetes mellitus.